Completed from United Kingdom
I loved the way the course broke down complex health‑economic concepts into bite‑size pieces. The practical workshops on Markov modelling helped me finally understand how to calculate QALYs for a real‑world vaccine rollout scenario. The lecture slides were neat and packed with real data from the UK NHS, which made everything feel applicable to my day‑to‑day work. While some topics could have used a bit more depth, the overall experience was solid and gave me confidence to talk about cost‑utility analysis with my colleagues.
The Pharmaceutical Health Economics course at Stanmore School of Business precisely matched my learning objectives. The modules on cost‑effectiveness analysis and budget impact modelling gave me the tools to build a full economic model for a new oncology drug, which I later presented to my employer’s senior management. The case studies were up‑to‑date and the reading list included the latest NICE guidelines, making the material immediately relevant. Overall, the instruction was clear, the assignments were challenging yet fair, and I left the course feeling fully equipped to contribute to health‑technology assessment projects.
Wow! This course blew me away with its hands‑on approach. The live simulation where we built a pharmacoeconomic model for a diabetes drug using Excel was a game‑changer – I can now run sensitivity analyses on my own! The instructor’s enthusiasm made the dense material feel exciting, and the supplemental videos on Indian health‑policy contexts were spot on. I walked away with a ready‑to‑use toolkit and even earned a certification that helped me land a new role in a pharma consulting firm.
The course offered a thorough, step‑by‑step exploration of health‑economic evaluation methods. I particularly appreciated the detailed walkthrough of the incremental cost‑effectiveness ratio (ICER) calculation, which I applied to a South African HIV prevention program in my final project. The reading materials included both classic textbooks and recent journal articles, ensuring a balanced perspective. Although the pacing was brisk, the instructor was always available for clarification, and the peer‑review assignments deepened my understanding. In sum, it was a highly valuable learning experience that directly supports my work in health‑policy analysis.
